PharmEasy CFO Steps Down To Join Entero Health

03 February, 2023 • VCCircle

PharmEasy might need to sell Thyrocare

01 February, 2023 • The Morning Context

PharmEasy FY22 loss widens to Rs 2,700 crore

27 December, 2022 • Bizz Buzz

  • Disclaimer

Investment Disclaimer

Investment in Pre IPO-Equity is subject to market risk. The investor should take an informed decision before investing in any company. Our research report must be used for informational purposes only. Planify will not be responsible for any Gain/loss on your investment.

Planify Disclaimer

An investment made on the Planify Platform is made through pooled investments that acquire shares of private companies and are not a direct investment in these companies.

Transaction Disclaimer

Planify facilitates the smooth execution of the transaction. If in case, Planify is not able to provide or supply the requisite agreed inventory, it will return the transaction amount in the same account through which the funds are received.